Wendy Lin

a.i. VP of Development & Regulatory Affairs

Wendy has over 20 years of professional multidisciplinary biotech and pharmaceutical experience, primarily in regulatory affairs, quality, process development and manufacturing. She has successfully led and designed global regulatory strategies (clinical, CMC and companion device) and CMC development strategies for over 50 early-to-late-stage small-molecule, biologic, ADC, gene therapy, oncolytic virus and protein-oligo conjugate programs across oncology, infectious disease, immunology, and rare disease indications. Wendy also has over 10 years of management and leadership experience running cross-department and multifunctional teams. Wendy’s last role was serving as head of development sciences at AbbVie SSF, overseeing Regulatory Affairs, Process Sciences, Manufacturing Sciences and Technology and Quality. More recently, Wendy has been formally and informally advising and investing in early-stage companies.

Wendy received a B.S. in Chemical Engineering from the University of California, Berkeley. She is a sponsored rock climber and spends her free time coaching and serving on various boards of non-profit outdoor and leadership organizations.

Curious about what we do? Get in touch!


About    Our Technology   Pipeline    Join us    News    Contact

T +31 85 800 8550

Tagworks Pharmaceuticals BV
Toernooiveld 1
6525 ED  Nijmegen
The Netherlands

Stay updated

© Tagworks Pharmaceuticals, 2024 | Terms of use | Design by Ape to Zebra